|
Volumn 29, Issue 2, 1996, Pages 199-203
|
Marker tumour response to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours. Report from the European Organisation for Research and Treatment on Cancer - Genitourinary Group (EORTC 30897)
a a a a a a |
Author keywords
Bacillus calmette guerin; Marker tumour; Mitomycin C; Superficial bladder cancer
|
Indexed keywords
BCG VACCINE;
MITOMYCIN C;
TUMOR MARKER;
ANTINEOPLASTIC ANTIBIOTIC;
IMMUNOLOGICAL ADJUVANT;
MITOMYCIN;
ADULT;
AGED;
ALLERGY;
ARTICLE;
BLADDER TUMOR;
BLEEDING;
CANCER SURGERY;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG RESPONSE;
ETIOLOGY;
FEMALE;
FEVER;
HUMAN;
INFLUENZA;
INTRAVESICAL DRUG ADMINISTRATION;
MALE;
MULTIPLE CANCER;
NAUSEA;
PRIORITY JOURNAL;
SKIN MANIFESTATION;
TUMOR GROWTH;
VOMITING;
CLINICAL TRIAL;
CLONOGENIC ASSAY;
IMMUNOLOGY;
IMMUNOTHERAPY;
LONGITUDINAL STUDY;
METABOLISM;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
TRANSITIONAL CELL CARCINOMA;
TUMOR RECURRENCE;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, INTRAVESICAL;
AGED;
AGED, 80 AND OVER;
ANTIBIOTICS, ANTINEOPLASTIC;
BCG VACCINE;
CARCINOMA, TRANSITIONAL CELL;
COLONY-FORMING UNITS ASSAY;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
IMMUNOTHERAPY;
LONGITUDINAL STUDIES;
MALE;
MIDDLE AGED;
MITOMYCIN;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASMS, MULTIPLE PRIMARY;
TUMOR MARKERS, BIOLOGICAL;
URINARY BLADDER NEOPLASMS;
|
EID: 0029665257
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (43)
|
References (0)
|